Astal Laboratories Ltd
Fundamental Score
Astal Laboratories Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ASTALLTD across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (30.10%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (34.78%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (15.05%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 9.61 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (29.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (185.11%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Excellent EPS Growth (161.53% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (212.84% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (12.32x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Negative Free Cash Flow (₹-31.64 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (18.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Astal Laboratories Ltd
About ASTALLTD
Business Overview
Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.
Company Details
Key Leadership
Corporate Events
ASTALLTD Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Astal Laboratories Ltd (ASTALLTD)?
As of 30 Jan 2026, 01:35 pm IST, Astal Laboratories Ltd (ASTALLTD) is currently trading at ₹79.58. The stock has a market capitalization of ₹95.11 (Cr).
Is ASTALLTD share price Overvalued or Undervalued?
ASTALLTD is currently trading at a P/E ratio of 9.61x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Astal Laboratories Ltd share price?
Key factors influencing ASTALLTD's price include its quarterly earnings growth (Sales Growth: 185.11%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Astal Laboratories Ltd a good stock for long-term investment?
Astal Laboratories Ltd shows a 5-year Profit Growth of 212.84% and an ROE of 30.10%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing.
How does Astal Laboratories Ltd compare with its industry peers?
Astal Laboratories Ltd competes with major peers in the Pharmaceuticals. Investors should compare ASTALLTD's P/E of 9.61x and ROE of 30.10% against the industry averages to determine its competitive standing.
What is the P/E ratio of ASTALLTD and what does it mean?
ASTALLTD has a P/E ratio of 9.61x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹10 for every ₹1 of annual earnings.
How is ASTALLTD performing according to Bull Run's analysis?
ASTALLTD has a Bull Run fundamental score of 58/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ASTALLTD belong to?
ASTALLTD operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Astal Laboratories Ltd.
What is Return on Equity (ROE) and why is it important for ASTALLTD?
ASTALLTD has an ROE of 30.10%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Astal Laboratories Ltd generates profits from shareholders' equity.
How is ASTALLTD's debt-to-equity ratio and what does it indicate?
ASTALLTD has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ASTALLTD's dividend yield and is it a good dividend stock?
ASTALLTD offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ASTALLTD grown over the past 5 years?
ASTALLTD has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 212.84%, and EPS Growth 161.53%.
What is the promoter holding in ASTALLTD and why does it matter?
Promoters hold 18.19% of ASTALLTD shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ASTALLTD's market capitalization category?
ASTALLTD has a market capitalization of ₹95 crores, placing it in the Small-cap category.
How volatile is ASTALLTD stock?
ASTALLTD has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ASTALLTD?
ASTALLTD has a 52-week high of ₹N/A and low of ₹N/A.
What is ASTALLTD's operating profit margin trend?
ASTALLTD has a 5-year average Operating Profit Margin (OPM) of 15.05%, indicating the company's operational efficiency.
How is ASTALLTD's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 185.11% and YoY Profit Growth of 29.00%.
What is the institutional holding pattern in ASTALLTD?
ASTALLTD has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.